SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14C - Definitive information statement relating to merger or acquisition:
SEC Accession No. 0001493152-24-008783
Filing Date
2024-03-05
Accepted
2024-03-05 08:16:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 formdefm14c.htm DEFM14C 1451367
2 annexb_001.jpg GRAPHIC 4540
  Complete submission text file 0001493152-24-008783.txt   1458997
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14C | Act: 34 | File No.: 001-36138 | Film No.: 24718375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)